Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Injection site haematoma, Injection site pain, Myalgia, Paraesthesia
Clinical narrative: weakness, tingling, and numbness affecting her left arm and leg; weakness, tingling, and numbness affecting her left arm and leg; difficulty standing/walking; weakness, tingling, and numbness affecting her left arm and leg; a bruise at the vaccination site, roughly the size of a half dollar/bruise at left arn injection site.; difficulty standing/walking; joint pain in the affected areas perticularly affecting left knee; mild fever until 100; pain, bruise at left arn injection site; body aches; Headache; This spontaneous case was reported by an other health care professional and describes the occurrence of ASTHENIA (weakness, tingling, and numbness affecting her left arm and leg), HYPOAESTHESIA (weakness, tingling, and numbness affecting her left arm and leg), GAIT DISTURBANCE (difficulty standing/walking), PARAESTHESIA (weakness, tingling, and numbness affecting her left arm and leg) and INJECTION SITE HAEMATOMA (a bruise at the vaccination site, roughly the size of a half dollar/bruise at left arn injection site.) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047A21A and 027C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension in 2018, Diabetes in 2019, Hypothyroidism in 2000, Acid reflux (esophageal) in 2010, Cholesterol high in 2015 and Drug allergy (Moviprep colonoscopy prep). Concomitant products included PANTOPRAZOLE for Acid reflux (esophageal), SIMVASTATIN for Cholesterol high, METFORMIN HYDROCHLORIDE (METFORMIN ER) for Diabetes, HCTZ for Fluid retention, LOSARTAN for Hypertension, LEVOTHYROXINE for Hypothyroidism, ACETYLSALICYLIC ACID (ASPIRIN) for an unknown indication.   On 29-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 29-Apr-2021, the patient experienced ASTHENIA (weakness, tingling, and numbness affecting her left arm and leg), HYPOAESTHESIA (weakness, tingling, and numbness affecting her left arm and leg), GAIT DISTURBANCE (difficulty standing/walking), PARAESTHESIA (weakness, tingling, and numbness affecting her left arm and leg), INJECTION SITE HAEMATOMA (a bruise at the vaccination site, roughly the size of a half dollar/bruise at left arn injection site.), DYSSTASIA (difficulty standing/walking), ARTHRALGIA (joint pain in the affected areas perticularly affecting left knee), PYREXIA (mild fever until 100), INJECTION SITE PAIN (pain, bruise at left arn injection site), MYALGIA (body aches) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency and NAPROXEN SODIUM (ALEVE) for Adverse event, at an unspecified dose and frequency. On 02-May-2021, ASTHENIA (weakness, tingling, and numbness affecting her left arm and leg), HYPOAESTHESIA (weakness, tingling, and numbness affecting her left arm and leg), GAIT DISTURBANCE (difficulty standing/walking), INJECTION SITE HAEMATOMA (a bruise at the vaccination site, roughly the size of a half dollar/bruise at left arn injection site.), DYSSTASIA (difficulty standing/walking), ARTHRALGIA (joint pain in the affected areas perticularly affecting left knee), PYREXIA (mild fever until 100), INJECTION SITE PAIN (pain, bruise at left arn injection site), MYALGIA (body aches) and HEADACHE (Headache) had resolved. At the time of the report, PARAESTHESIA (weakness, tingling, and numbness affecting her left arm and leg) had resolved. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.       Most recent FOLLOW-UP information incorporated above includes: On 08-May-2021: Follow-up received included updates to medical history, concomitant medications, and events.